Protalix BioTherapeutics, Inc.

Protalix BioTherapeutics, Inc., a biopharmaceutical company, through Protalix Ltd., focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system in the United States.

Ticker:
PLX
Exchange:
AMEX (See More AMEX Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?